St. Jude Children's Research Hospital - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
圣裘德儿童研究医院 - 艾滋病毒/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
基本信息
- 批准号:10599563
- 负责人:
- 金额:$ 45.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-22 至 2029-06-30
- 项目状态:未结题
- 来源:
- 关键词:AIDS/HIV problemAcademiaAcquired Immunodeficiency SyndromeAddressAdolescentAdolescent MedicineAdolescent Medicine Trials NetworkAfrican American populationAgeAreaArkansasBehavioralBlack PopulationsCitiesClinicClinical ResearchClinical TrialsClinical Trials DesignCollaborationsCommunitiesCountyDevelopmentDiagnosisEpidemicFundingGeneral PopulationGeographyHIVHIV InfectionsHealthHealthcareHuman ResourcesIncomeIndividualInfectionInfrastructureInterventionIntervention StudiesInvestigationLaboratoriesLeadershipMinorMississippiMissouriNamesPersonsPharmacy facilityPoliciesPopulationPovertyPublic HealthRadialResearch InfrastructureResearch PersonnelRiskSaint Jude Children&aposs Research HospitalSchoolsSiteStrategic PlanningTennesseeThinkingTimeUnited StatesUniversitiesWritingYouthbaseclinical developmentclinical research siteclinical trial implementationcommunity partnershipcomorbiditydesigninfection rateinnovationinterestmeetingsmetropolitanmicrobicidenovelnovel strategiesoperationpandemic diseasepreventrecruitresearch facilityrural areatranslational therapeuticsurban areavaccine trialvirtual
项目摘要
ABSTRACT St. Jude Children's Research Hospital
The Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) aims over the 7-year funding cycle
to develop and conduct innovative behavioral, community-based, translational, therapeutic, microbicide, and
vaccine trials in youth ages 13-24 years at-risk for HIV and living with HIV, with a focus on the inclusion of
minors. The ATN seeks investigators with innovative thinking and novel approaches to address the public
health issues facing adolescents. The St. Jude Memphis Site Consortium (SMSC), based in Memphis located
in the Shelby County of TN has (1) a well-established clinical and clinical research facility at St. Jude Children's
Research Hospital (former ATN site), (2) A long-standing Connect to Protect Memphis Coalition (C2P
Memphis) of over 25 stakeholders (Community Based organizations, Non for Profit Groups, Memphis Schools,
etc.) invested in the interests of youth and (3) established partnerships including with academia (University of
Tennessee) and the local Shelby County and Tennessee state health departments. Shelby County is an
Ending the HIV Epidemic Priority jurisdiction. The SMSC closely collaborating with the Westat led ATN
Operations and Collaborations Center (OCC) will participate in the development of clinical trials and provide
the clinical research site(s), local laboratory capacity, and investigational pharmacy support to further the ATN
Research agenda. Taking the clinical trials to youth at risk of HIV and those living with HIV who are not aware
of their diagnosis will require using innovative approaches for recruitment which the SMSC has demonstrated
in the past and looks forward to building on. The C2P Memphis Coalition and a separate youth community
advisory board will over the project period be instrumental in providing input both for clinical trial design as well
as youth engagement and retention approaches.
圣裘德儿童研究医院
艾滋病毒/艾滋病干预青少年医学试验网络(ATN)的目标是在7年的供资周期内,
开发和开展创新的行为,社区为基础的,转化,治疗,杀微生物剂,
在13-24岁的艾滋病毒高危青年和艾滋病毒感染者中进行疫苗试验,重点是纳入
未成年人ATN寻求具有创新思维和新颖方法的调查人员来解决公众问题
青少年面临的健康问题。位于孟菲斯的圣犹达孟菲斯研究中心联盟(SMSC)位于
在田纳西州谢尔比县有(1)一个完善的临床和临床研究机构在圣裘德儿童医院
研究医院(前ATN网站),(2)一个长期的连接保护孟菲斯联盟(C2 P
孟菲斯)超过25个利益相关者(社区组织,非营利组织,孟菲斯学校,
等等)。投资于青年的利益;(3)建立伙伴关系,包括与学术界(大学)
田纳西州)和当地谢尔比县和田纳西州卫生部门。谢尔比县是一个
终止艾滋病毒流行病优先管辖权。SMSC与Westat领导的ATN密切合作
运营和协作中心(OCC)将参与临床试验的开发,并提供
临床研究中心、当地实验室能力和研究药物支持,以促进ATN
研究议程。对有感染艾滋病毒风险的青年和不知情的艾滋病毒感染者进行临床试验
他们的诊断将需要使用创新的招聘方法,
C2 P孟菲斯联盟和一个独立的青年社区
咨询委员会将在项目期间为临床试验设计提供投入
随着青年参与和留住青年的办法越来越多。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Aditya H Gaur其他文献
A call to accelerate antiretroviral development for neonates
呼吁加快新生儿抗逆转录病毒药物的研发
- DOI:
10.1016/s2352-3018(23)00307-7 - 发表时间:
2024-02-01 - 期刊:
- 影响因子:13.000
- 作者:
Aditya H Gaur;George K Siberry - 通讯作者:
George K Siberry
Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study.
口服和长效注射剂卡博特韦或长效注射剂利匹韦林在病毒学抑制的青少年 HIV 患者中的安全性和药代动力学 (IMPAACT 2017/MOCHA):一项 1/2 期、多中心、开放标签、非比较、剂量探索研究
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
Aditya H Gaur;Edmund V. Capparelli;Katherine Calabrese;Kristin Baltrusaitis;M. Marzinke;Cindy McCoig;R. V. Van Solingen;S. R. Mathiba;A. Adeyeye;Jack Moye;Barbara Heckman;Elizabeth D Lowenthal;Shawn Ward;Ryan Milligan;P. Samson;B. Best;Conn M. Harrington;Susan L Ford;Jenny Huang;Herta Crauwels;Kati Vandermeulen;Allison L Agwu;Christiana Smith;Andres Camacho;P. Ounchanum;Jared L Kneebone;Ellen Townley;Carolyn Bolton Moore - 通讯作者:
Carolyn Bolton Moore
Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT 2017/MOCHA): a secondary analysis of a phase 1/2, multicentre, open-label, non-comparative dose-finding study.
长效注射剂卡博特韦或利匹韦林在第一批病毒学受到抑制的青少年 HIV 感染者中的可接受性和耐受性 (IMPAACT 2017/MOCHA):1/2 期、多中心、开放标签、非比较剂量的二次分析
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
Elizabeth D Lowenthal;Jennifer Chapman;Rachel Ohrenschall;Katherine Calabrese;Kristin Baltrusaitis;Barbara Heckman;Dwight E Yin;Allison L Agwu;Conn M. Harrington;R. V. Van Solingen;Cindy McCoig;A. Adeyeye;Jared L Kneebone;Vasiliki Chounta;Christiana Smith;Andres Camacho;Jessica D'Angelo;Allison Bearden;Herta Crauwels;Jenny Huang;Sarah Buisson;Ryan Milligan;Shawn Ward;C. Bolton;Aditya H Gaur - 通讯作者:
Aditya H Gaur
Pharmacokinetics and safety of coformulated bictegravir, emtricitabine, and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV: a phase 2/3, open-label, single-arm study
在病毒学抑制的 2 岁及以上儿童中,固定剂量复方比克替拉韦、恩曲他滨和丙酚替诺福韦的药代动力学和安全性:一项 2/3 期、开放标签、单臂研究
- DOI:
10.1016/s2352-3018(23)00327-2 - 发表时间:
2024-05-01 - 期刊:
- 影响因子:13.000
- 作者:
Carina A Rodriguez;Eva Natukunda;Renate Strehlau;Esme L Venter;Supattra Rungmaitree;Coleen K Cunningham;Umesh Lalloo;Pope Kosalaraksa;Elizabeth HellstrÖm;Afaaf Liberty;Eric J McGrath;Meenu Kaur;Rory Leisegang;Jason T Hindman;Vinicius A Vieira;Kathryn Kersey;Mark F Cotton;Natella Rakhmanina;Aditya H Gaur - 通讯作者:
Aditya H Gaur
Aditya H Gaur的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Aditya H Gaur', 18)}}的其他基金
St. Jude Children's Research Hospital - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
圣裘德儿童研究医院 - 艾滋病毒/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
- 批准号:
10709610 - 财政年份:2022
- 资助金额:
$ 45.66万 - 项目类别:
相似海外基金
Conference: Rethinking how language background is described in academia and beyond
会议:重新思考学术界及其他领域如何描述语言背景
- 批准号:
2335912 - 财政年份:2024
- 资助金额:
$ 45.66万 - 项目类别:
Standard Grant
ADVANCE Catalyst: Virtual Observatory of Culture for Equity in Academia at the University of Puerto Rico Rio Piedras (VoCEA)
ADVANCE Catalyst:波多黎各 Rio Piedras 大学学术界平等文化虚拟观察站 (VoCEA)
- 批准号:
2214418 - 财政年份:2023
- 资助金额:
$ 45.66万 - 项目类别:
Standard Grant
Comprehensive development strategy of modality-specific "intellectual property" and "cultivation" with an eye on "pharmaceutical affairs" in academia drug discovery
学术界新药研发着眼“药事”的模式“知识产权”与“培育”综合发展策略
- 批准号:
23K02551 - 财政年份:2023
- 资助金额:
$ 45.66万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating Research Advancement for Investigators Underrepresented in Academia
加速学术界代表性不足的研究人员的研究进展
- 批准号:
10746315 - 财政年份:2023
- 资助金额:
$ 45.66万 - 项目类别:
Planning: HBCU-UP: Strengthening Data Science Research Capacity and Education Programs through Academia-Industry Partnership
规划:HBCU-UP:通过学术界与工业界合作加强数据科学研究能力和教育计划
- 批准号:
2332161 - 财政年份:2023
- 资助金额:
$ 45.66万 - 项目类别:
Standard Grant
From Academia to Business: Development of Novel Therapeutics Against HPV-Associated Cancer
从学术界到商界:针对 HPV 相关癌症的新型疗法的开发
- 批准号:
10813323 - 财政年份:2023
- 资助金额:
$ 45.66万 - 项目类别:
Academics4Rail: Building a Community of Railway Scientific Researchers and Academia for ERJU and Enabling a Network of PhDs (Academia Teaming with Industry)
Academys4Rail:为二院建立铁路科研人员和学术界社区并启用博士网络(学术界与工业界合作)
- 批准号:
10102850 - 财政年份:2023
- 资助金额:
$ 45.66万 - 项目类别:
EU-Funded
Academics4Rail: Building a community of railway scientific researchers and academia for ERJU and enabling a network of PhDs (academia teaming with industry)
Academys4Rail:为ERJU建立铁路科研人员和学术界社区并建立博士网络(学术界与工业界合作)
- 批准号:
10087488 - 财政年份:2023
- 资助金额:
$ 45.66万 - 项目类别:
EU-Funded
Exploring the overall picture of industry-academia-government collaboration: A spectrum of knowledge transfer through formal and informal channels
探索产学官合作的整体图景:通过正式和非正式渠道进行的一系列知识转移
- 批准号:
22K01692 - 财政年份:2022
- 资助金额:
$ 45.66万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Fostering Ethical Neurotechnology Academia-Industry Partnerships: A Stakeholder Engagement and Toolkit Development Project
促进道德神经技术学术界与工业界的伙伴关系:利益相关者参与和工具包开发项目
- 批准号:
10655632 - 财政年份:2022
- 资助金额:
$ 45.66万 - 项目类别: